Market Value9,537,918,000
Total Holdings135
File Date2016-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INCY / Incyte Corporation
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
GWP / GW Pharmaceuticals plc
LIFE / aTyr Pharma, Inc.
XNPT / XenoPort, Inc.
MGNX / MacroGenics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
BCRX / BioCryst Pharmaceuticals, Inc.
BDSI / Biodelivery Sciences International
220480AB3 / Amrn 3.5 1/32 Bond
US189464AB64 / Clovis Oncology, Inc. 2.5% 9/15/2021
CNCE / Concert Pharmaceuticals Inc
DMTX / Dimension Therapeutics, Inc.
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
ZGNX / Zogenix Inc
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
ABBV / AbbVie Inc.
SCYX / SCYNEXIS, Inc.
PTN / Palatin Technologies, Inc.
CMRX / Chimerix, Inc.
ECYT / Endocyte, Inc.
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
IRWD / Ironwood Pharmaceuticals, Inc.
98411CAB6 / XenoPort, Inc. Bonds 2.5% 2/1/2022
OMER / Omeros Corporation
ALDR / Alder BioPharmaceuticals, Inc.
EXEL / Exelixis, Inc.
VTAE / Vitae Pharmaceuticals, Inc.
NDRM / NeuroDerm Ltd.
ABUS / Arbutus Biopharma Corporation
SELB / Selecta Biosciences Inc
APTO / Aptose Biosciences Inc.
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
PRQR / ProQR Therapeutics N.V.
GLYC / GlycoMimetics, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
IMDZ / Immune Design Corp.
451731103 / Ignyta, Inc.
MDWD / MediWound Ltd.
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
/ Array BioPharma, Inc.
AAAP / Advanced Accelerator Applications S.A
FMI / Foundation Medicine, Inc.
032420101 / Anacor Pharmaceuticals, Inc.
GNMX / Aevi Genomic Medicine, Inc.
SVRA / Savara Inc.
JUNO / Juno Therapeutics, Inc.
OSIR / Osiris Therapeutics, Inc.
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
US00448Q2012 / Achillion Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
GHDX / Genomic Health, Inc.
30161QAC8 / Exelixis, Inc. Bond
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
LGND / Ligand Pharmaceuticals Incorporated
STML / Stemline Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ALNY / Alnylam Pharmaceuticals, Inc.
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
ONCE / Spark Therapeutics, Inc.
AERI / Aerie Pharmaceuticals Inc
CRIS / Curis, Inc.
MDVN / Medivation, Inc.
CYTR / LadRx Corp
ADMS / Adamas Pharmaceuticals Inc
INSM / Insmed Incorporated
IDRA / Idera Pharmaceuticals, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
ACOR / Acorda Therapeutics, Inc.
TRIL / Trillium Therapeutics Inc
SGMO / Sangamo Therapeutics, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
HALO / Halozyme Therapeutics, Inc.
NVIV / InVivo Therapeutics Holdings Corp.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
NBRV / Nabriva Therapeutics Plc
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
WINT / Windtree Therapeutics, Inc.
CERS / Cerus Corporation
US33830X1046 / Five Prime Therapeutics Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TENX / Tenax Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
DERM / Journey Medical Corporation
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
TRVN / Trevena, Inc.
MCRB / Seres Therapeutics, Inc.
/ Achaogen Inc
ACAD / ACADIA Pharmaceuticals Inc.
ITCI / Intra-Cellular Therapies, Inc.
TGTX / TG Therapeutics, Inc.
EPZM / Epizyme Inc
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
LOXO / Loxo Oncology, Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
AUPH / Aurinia Pharmaceuticals Inc.
ISEE / IVERIC bio Inc
MRUS / Merus N.V.
NTLA / Intellia Therapeutics, Inc.
NERV / Minerva Neurosciences, Inc.
NBIX / Neurocrine Biosciences, Inc.
KPTI / Karyopharm Therapeutics Inc.
XLRN / Acceleron Pharma Inc
ALDX / Aldeyra Therapeutics, Inc.
LJPC / La Jolla Pharmaceutical Co.
AGIO / Agios Pharmaceuticals, Inc.
QLGN / Qualigen Therapeutics, Inc.
SRRA / Sierra Oncology Inc
DSCI / Derma Sciences, Inc.
GBT / Global Blood Therapeutics Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
CCXI / ChemoCentryx Inc
BLUE / bluebird bio, Inc.
SAGE / Sage Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
NVAX / Novavax, Inc.
IONS / Ionis Pharmaceuticals, Inc.
SYRS / Syros Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
DVAX / Dynavax Technologies Corporation
XNCR / Xencor, Inc.
TARA / Protara Therapeutics, Inc.
ALKS / Alkermes plc
MDGL / Madrigal Pharmaceuticals, Inc.
IMGN / ImmunoGen, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
NTRA / Natera, Inc.
AFMD / Affimed N.V.
VIRX / Viracta Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
ASMB / Assembly Biosciences, Inc.
SGEN / Seagen Inc
HRTX / Heron Therapeutics, Inc.
ARAV / Aravive, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
NVTA / Invitae Corporation
MRTX / Mirati Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc